lansoprazole has been researched along with Dermatitis Medicamentosa in 9 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology." | 7.73 | Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005) |
| " pylori-infected patients with endoscopically documented duodenal ulcer either currently or within the past year were randomized to 14 days of (1) lansoprazole, 30 mg bid, plus amoxicillin, 1 gm tid; (2) lansoprazole, 30 mg tid, plus amoxicillin, 1 gm tid; (3) lansoprazole, 30 mg tid alone; or (4) amoxicillin, 1 gm tid alone." | 5.08 | Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. ( Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A, 1996) |
| "After 2 months of treatment with imatinib 400 mg/day, a 60-year-old white female affected by GIST developed bilateral palpebral edema with hyperemic conjunctivae and labial edema when lansoprazole 15 mg/day was introduced to treat dyspeptic symptomatology." | 3.73 | Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. ( Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbaud, A | 1 |
| Alkeraye, S | 1 |
| Baclet, Y | 1 |
| Delaporte, E | 1 |
| Chularojanamontri, L | 1 |
| Jiamton, S | 1 |
| Manapajon, A | 1 |
| Suvanasuthi, S | 1 |
| Kulthanan, K | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| Severino, G | 1 |
| Chillotti, C | 1 |
| De Lisa, R | 1 |
| Del Zompo, M | 1 |
| Ardau, R | 1 |
| Heaton, NR | 1 |
| Edmonds, EV | 1 |
| Francis, ND | 1 |
| Bunker, CB | 1 |
| Bowling, JC | 1 |
| Morar, N | 1 |
| Revuz, J | 1 |
| Harford, W | 1 |
| Lanza, F | 1 |
| Arora, A | 1 |
| Graham, D | 1 |
| Haber, M | 1 |
| Weissfeld, A | 1 |
| Rose, P | 1 |
| Siepman, N | 1 |
| Cockayne, SE | 1 |
| Glet, RJ | 1 |
| Gawkrodger, DJ | 1 |
| McDonagh, AJ | 1 |
| Bong, JL | 1 |
| Lucke, TW | 1 |
| Douglas, WS | 1 |
1 trial available for lansoprazole and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diar | 1996 |
8 other studies available for lansoprazole and Dermatitis Medicamentosa
| Article | Year |
|---|---|
[Current findings on drug-induced skin reactions].
Topics: Cephalosporins; Drug Eruptions; France; Glucocorticoids; Humans; Hypersensitivity, Delayed; Lansopra | 2017 |
Sticky Palms Following Use of Proton-Pump Inhibitors.
Topics: Administration, Oral; Adult; Drug Eruptions; Esomeprazole; Female; Gastroesophageal Reflux; Hand Der | 2016 |
Cutaneous reactions to proton pump inhibitors: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Cas | 2012 |
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antineoplastic Agents; Benzamides; Drug Eruptions; Edema; F | 2005 |
Fatal toxic epidermal necrolysis due to lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Drug Eruptions; Erythema Multiform | 2004 |
Fatal toxic epidermal necrolysis due to lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Diagnosis, Differential; Drug Eruptions; | 2006 |
Severe erythrodermic reactions to the proton pump inhibitors omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Dermatitis, Exfoliative; Drug Erup | 1999 |
Lichenoid drug eruption with proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Drug Eruptions; En | 2000 |